RhumbLine Advisers’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-80,564
| Closed | -$92K | – | 3294 |
|
|
2022
Q1 | $92K | Buy |
80,564
+5,742
| +8% | +$6.56K | ﹤0.01% | 2900 |
|
|
2021
Q4 | $168K | Sell |
74,822
-1,006
| -1% | -$2.26K | ﹤0.01% | 2872 |
|
|
2021
Q3 | $259K | Buy |
75,828
+4,289
| +6% | +$14.7K | ﹤0.01% | 2822 |
|
|
2021
Q2 | $214K | Buy |
+71,539
| New | +$214K | ﹤0.01% | 2909 |
|
|
2017
Q2 | – | Sell |
-65,077
| Closed | -$210K | – | 2970 |
|
|
2017
Q1 | $210K | Buy |
65,077
+17,452
| +37% | +$56.3K | ﹤0.01% | 2638 |
|
|
2016
Q4 | $64K | Sell |
47,625
-34,964
| -42% | -$47K | ﹤0.01% | 2818 |
|
|
2016
Q3 | $129K | Buy |
82,589
+700
| +0.9% | +$1.09K | ﹤0.01% | 2774 |
|
|
2016
Q2 | $109K | Buy |
81,889
+27,897
| +52% | +$37.1K | ﹤0.01% | 2905 |
|
|
2016
Q1 | $285K | Buy |
53,992
+420
| +0.8% | +$2.22K | ﹤0.01% | 2553 |
|
|
2015
Q4 | $421K | Buy |
53,572
+4,420
| +9% | +$34.7K | ﹤0.01% | 2359 |
|
|
2015
Q3 | $415K | Sell |
49,152
-259
| -0.5% | -$2.19K | ﹤0.01% | 2361 |
|
|
2015
Q2 | $541K | Sell |
49,411
-2,115
| -4% | -$23.2K | ﹤0.01% | 2272 |
|
|
2015
Q1 | $720K | Buy |
51,526
+6,375
| +14% | +$89.1K | ﹤0.01% | 2068 |
|
|
2014
Q4 | $763K | Sell |
45,151
-850
| -2% | -$14.4K | ﹤0.01% | 1989 |
|
|
2014
Q3 | $617K | Sell |
46,001
-100
| -0.2% | -$1.34K | ﹤0.01% | 2081 |
|
|
2014
Q2 | $587K | Buy |
46,101
+52
| +0.1% | +$662 | ﹤0.01% | 2166 |
|
|
2014
Q1 | $548K | Sell |
46,049
-2,340
| -5% | -$27.8K | ﹤0.01% | 2164 |
|
|
2013
Q4 | $668K | Sell |
48,389
-2,100
| -4% | -$29K | ﹤0.01% | 2073 |
|
|
2013
Q3 | $881K | Buy |
50,489
+1,323
| +3% | +$23.1K | ﹤0.01% | 1863 |
|
|
2013
Q2 | $799K | Buy |
+49,166
| New | +$799K | ﹤0.01% | 1916 |
|